Senegal has secured the patent right to manufacture COVID-19 vaccines in mid-2022.
This move is aimed at boosting Africa’s drug-manufacturing ambitions and vaccinating the continent’s populace against the virus.
The West African country signed a deal on Monday with a Belgian biotech group Univercells to produce the jabs.
Institut Pasteur in Senegal is to use vaccine production technology developed by Univercells to supply COVID-19 vaccine shots to countries across West Africa.
The institute would initially begin packaging and distributing vaccines produced by Univercells in Belgium early next year, while Univercells would transfer its full production line to Senegal in the second half of 2022.
It is reported that local staffs would be trained so they could eventually run operations.
On a continent of 1.3 billion, only about 7 million have been fully vaccinated.